# ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.

> **NCT04961528** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 315 (actual)

## Conditions studied

- Hemoptysis

## Interventions

- **DRUG:** Tranexamic Acid 500 MG
- **DRUG:** Terlipressin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04961528
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-27
- **Primary completion:** 2025-12-28
- **Final completion:** 2026-03-25
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04961528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04961528, "ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04961528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*